Published in Anticancer Drugs on March 01, 2009
Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study. J Cancer Res Clin Oncol (2014) 0.75
Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma. Sci Pharm (2011) 0.85
Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients. Hematology (2013) 0.83
Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. J Pharm Pharmacol (2014) 0.82
Prevalence of tobacco smoking among health-care physicians in Bahrain. BMC Public Health (2014) 0.81
Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clin Exp Metastasis (2015) 0.78
Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy. Ann Hematol (2014) 0.77
64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. Acta Radiol (2012) 0.77
Validity of osteoprotegerin and receptor activator of NF-κB ligand for detection of bone metastasis in breast cancer. Oncol Res (2016) 0.75
Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Sci Pharm (2013) 0.75
Cytotoxic effects of suramin against HepG2 cells through activation of intrinsic apoptotic pathway. J BUON (2014) 0.75
Prognostic significance of FLT3 internal tandem duplication in egyptian patients with acute myeloid leukemia with normal or favorable risk cytogenetics. Egypt J Immunol (2010) 0.75